Atlas Trials

OBI Pharma, Inc

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch OBI Pharma, Inc

RecordFirmDate
A Study Evaluating OBI-902 in Participants With Advanced Solid Tumors (NCT07124117)OBI Pharma, Inc2025-08-04
A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors (NCT06480240)OBI Pharma, Inc2024-06-12
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT05442060)OBI Pharma, Inc2022-07-27
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors (NCT04084366)OBI Pharma, Inc2019-11-25
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC (NCT03562637)OBI Pharma, Inc2018-12-05
A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors (NCT03592264)OBI Pharma, Inc2018-07-02
This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. (NCT03573544)OBI Pharma, Inc2018-05-07

Track OBI Pharma, Inc automatically

Every clearance here is in the API, with alerts when new ones post.